1 undecene  (Millipore)


Bioz Verified Symbol Millipore is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Name:
    1 Undecene
    Description:
    1 Undecene is one of the constituents of the essential oil from Farfugium japonicum
    Catalog Number:
    242527
    Price:
    None
    Applications:
    1-Undecene was used as a biomarker for identification of Pseudomonas aeruginosa strain.
    Buy from Supplier


    Structured Review

    Millipore 1 undecene
    1 Undecene
    1 Undecene is one of the constituents of the essential oil from Farfugium japonicum
    https://www.bioz.com/result/1 undecene/product/Millipore
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    1 undecene - by Bioz Stars, 2020-09
    94/100 stars

    Images

    1) Product Images from "Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii"

    Article Title: Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii

    Journal: Frontiers in Microbiology

    doi: 10.3389/fmicb.2015.01082

    Average of mycelia growth (%) of strains DS256, DS270, and DS226, DS284 of Pleurotus eryngii and P. ostreatus , respectively, in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.
    Figure Legend Snippet: Average of mycelia growth (%) of strains DS256, DS270, and DS226, DS284 of Pleurotus eryngii and P. ostreatus , respectively, in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.

    Techniques Used:

    Agaricus bisporus (1) and Pleurotus ostreatus (2) basidiome tissue blocks treated with pure 1-undecene aliquots ( 1A and 2A = H 2 O; 1B and 2B = 2.5 μg; 1C and 2C = 5 μg; 1D and 2D = 10 μg; 1E and 2E = 25 μg; 1F and 2F = 50 μg) .
    Figure Legend Snippet: Agaricus bisporus (1) and Pleurotus ostreatus (2) basidiome tissue blocks treated with pure 1-undecene aliquots ( 1A and 2A = H 2 O; 1B and 2B = 2.5 μg; 1C and 2C = 5 μg; 1D and 2D = 10 μg; 1E and 2E = 25 μg; 1F and 2F = 50 μg) .

    Techniques Used:

    Average growth (%) of whole seedlings ( ), epicotyls ( ), and main rootlets ( ) of broccoli in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.
    Figure Legend Snippet: Average growth (%) of whole seedlings ( ), epicotyls ( ), and main rootlets ( ) of broccoli in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.

    Techniques Used:

    Volatile compounds produced by Pseudomonas tolaasii strains (NCPPB2192, USB1, and USB66) . 1- carbon dioxide (CO 2 ); 2- methanethiol (MT); 3- dimethyl disulfide (DMDS); 4- p -cymene; 5, 1,4-undecadiene; 6- 1-undecene; 7- 2-undecanone; 8- 4,7-dimethylundecane.
    Figure Legend Snippet: Volatile compounds produced by Pseudomonas tolaasii strains (NCPPB2192, USB1, and USB66) . 1- carbon dioxide (CO 2 ); 2- methanethiol (MT); 3- dimethyl disulfide (DMDS); 4- p -cymene; 5, 1,4-undecadiene; 6- 1-undecene; 7- 2-undecanone; 8- 4,7-dimethylundecane.

    Techniques Used: Produced

    2) Product Images from "Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii"

    Article Title: Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii

    Journal: Frontiers in Microbiology

    doi: 10.3389/fmicb.2015.01082

    Average of mycelia growth (%) of strains DS256, DS270, and DS226, DS284 of Pleurotus eryngii and P. ostreatus , respectively, in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.
    Figure Legend Snippet: Average of mycelia growth (%) of strains DS256, DS270, and DS226, DS284 of Pleurotus eryngii and P. ostreatus , respectively, in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.

    Techniques Used:

    Agaricus bisporus (1) and Pleurotus ostreatus (2) basidiome tissue blocks treated with pure 1-undecene aliquots ( 1A and 2A = H 2 O; 1B and 2B = 2.5 μg; 1C and 2C = 5 μg; 1D and 2D = 10 μg; 1E and 2E = 25 μg; 1F and 2F = 50 μg) .
    Figure Legend Snippet: Agaricus bisporus (1) and Pleurotus ostreatus (2) basidiome tissue blocks treated with pure 1-undecene aliquots ( 1A and 2A = H 2 O; 1B and 2B = 2.5 μg; 1C and 2C = 5 μg; 1D and 2D = 10 μg; 1E and 2E = 25 μg; 1F and 2F = 50 μg) .

    Techniques Used:

    Average growth (%) of whole seedlings ( ), epicotyls ( ), and main rootlets ( ) of broccoli in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.
    Figure Legend Snippet: Average growth (%) of whole seedlings ( ), epicotyls ( ), and main rootlets ( ) of broccoli in presence of pure MT (A) , DMDS (B) , and 1-undecene (C) aliquots . Bars on the columns correspond to the standard error of the mean in percentage.

    Techniques Used:

    Volatile compounds produced by Pseudomonas tolaasii strains (NCPPB2192, USB1, and USB66) . 1- carbon dioxide (CO 2 ); 2- methanethiol (MT); 3- dimethyl disulfide (DMDS); 4- p -cymene; 5, 1,4-undecadiene; 6- 1-undecene; 7- 2-undecanone; 8- 4,7-dimethylundecane.
    Figure Legend Snippet: Volatile compounds produced by Pseudomonas tolaasii strains (NCPPB2192, USB1, and USB66) . 1- carbon dioxide (CO 2 ); 2- methanethiol (MT); 3- dimethyl disulfide (DMDS); 4- p -cymene; 5, 1,4-undecadiene; 6- 1-undecene; 7- 2-undecanone; 8- 4,7-dimethylundecane.

    Techniques Used: Produced

    Related Articles

    Gas Chromatography-Mass Spectrometry:

    Article Title: Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii
    Article Snippet: .. Furthermore, the identity of some of the VOCs components was confirmed by GC–MS analysis of reference substances [acetaldehyde (Sigma–Aldrich, 402788); methanethiol (MT) (Sigma–Aldrich, 295515); DMDS (Sigma–Aldrich, W353604); p -cymene (Sigma–Aldrich, C121452); 1-undecene (Sigma–Aldrich, 242527); 2-undecanone (Sigma–Aldrich, U1303)] used as control. .. The volatile relative concentrations in each Petri plate were calculated based on GC–MS peak areas without using correction factors.

    Article Title: Bioactivity of volatile organic compounds produced by Pseudomonas tolaasii
    Article Snippet: .. VOCs Bioassays In order to evaluate VOCs bioactivity, identified by GC-MS, belonging to P. tolaasii strains volatile mixture, three pure VOCs, DMDS, MT, and 1-undecene (Sigma–Aldrich, Milan, Italy), selected on the basis of their detection for all the P. tolaasii strains, were used in mushrooms and seeds bioassays. .. In these bioassays P. ostreatus mycelium plugs, A. bisporus and P. ostreatus basidiome tissue blocks and 100 broccoli seeds, were placed in two out three sectors of Petri dishes, while in the third one were dropped or injected, according to their physical state, DMDS, 1-undecene, and MT.

    other:

    Article Title: A simple method for the quantification of molecular decorations on silica particles
    Article Snippet: Chemicals and reagents 3-Mercaptopropyltrimethoxysilane (MPTMS) (95%), benzophenone ( > 99%), 11-bromo-1-undecene (95%) and 10-bromo-1-undecene (95%) were purchased from Sigma- Aldrich and used as received.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96
    Millipore anti ccr3
    HIV-1 alternative receptors expression and cell-free entry in Tcam-2. ( A ) Potential HIV receptors was assessed on the surface of Tcam-2 cells labelled for DDX4 using specific antibodies against CD4, CCR5, CXCR4, <t>CCR3,</t> GalactosylCeramide (GalCer) and HSPGs, or following detection of BSA-Mannose, a ligand for mannose receptor. Immunolabelling was analyzed by flow cytometry. ( B ) HIV-1 entry was assessed in CFSE-labelled Tcam-2 cells (in green) exposed for 4h to a primary R5-tropic HIV-1 strain (ES X-2556-3) or mock exposed, before immunolabelling with p24 antibody (red). Nuclei were stained with DAPI (blue). ( C ) HIV-1 reverse transcription was assessed by qPCR on Tcam-2 cells cultured 24h with or without the reverse transcriptase inhibitor nevirapin, following exposure to HIV R5 JR-CSF HIV-1 (n=6).
    Anti Ccr3, supplied by Millipore, used in various techniques. Bioz Stars score: 96/100, based on 0 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ccr3/product/Millipore
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti ccr3 - by Bioz Stars, 2020-09
    96/100 stars
      Buy from Supplier

    Image Search Results


    HIV-1 alternative receptors expression and cell-free entry in Tcam-2. ( A ) Potential HIV receptors was assessed on the surface of Tcam-2 cells labelled for DDX4 using specific antibodies against CD4, CCR5, CXCR4, CCR3, GalactosylCeramide (GalCer) and HSPGs, or following detection of BSA-Mannose, a ligand for mannose receptor. Immunolabelling was analyzed by flow cytometry. ( B ) HIV-1 entry was assessed in CFSE-labelled Tcam-2 cells (in green) exposed for 4h to a primary R5-tropic HIV-1 strain (ES X-2556-3) or mock exposed, before immunolabelling with p24 antibody (red). Nuclei were stained with DAPI (blue). ( C ) HIV-1 reverse transcription was assessed by qPCR on Tcam-2 cells cultured 24h with or without the reverse transcriptase inhibitor nevirapin, following exposure to HIV R5 JR-CSF HIV-1 (n=6).

    Journal: bioRxiv

    Article Title: Potential for virus endogenization in humans through testicular germ cell infection: the case of HIV

    doi: 10.1101/2020.06.04.135657

    Figure Lengend Snippet: HIV-1 alternative receptors expression and cell-free entry in Tcam-2. ( A ) Potential HIV receptors was assessed on the surface of Tcam-2 cells labelled for DDX4 using specific antibodies against CD4, CCR5, CXCR4, CCR3, GalactosylCeramide (GalCer) and HSPGs, or following detection of BSA-Mannose, a ligand for mannose receptor. Immunolabelling was analyzed by flow cytometry. ( B ) HIV-1 entry was assessed in CFSE-labelled Tcam-2 cells (in green) exposed for 4h to a primary R5-tropic HIV-1 strain (ES X-2556-3) or mock exposed, before immunolabelling with p24 antibody (red). Nuclei were stained with DAPI (blue). ( C ) HIV-1 reverse transcription was assessed by qPCR on Tcam-2 cells cultured 24h with or without the reverse transcriptase inhibitor nevirapin, following exposure to HIV R5 JR-CSF HIV-1 (n=6).

    Article Snippet: The following antibodies were used: anti-CD45 (-PE or PC7 conjugated, HI30, BD Pharmingen), anti-HLA-ABC-PE (G46-2.6, BD Pharmingen) anti-Vimentin (EPR3776, 1µg/mL, Epitomics), anti-DDX4 (Rabbit polyclonal, 5µg/mL, Abcam), anti-MAGEA4 (clone 57B, 4µg/mL) [ ], anti-CD4 (ARP337, 10µg/mL), anti-CXCR4 (ARP3101 12G5, 10µg/mL) (both from EVA/MRC, NIBSC), anti-CCR5 (45549, 10µg/mL, R & D), anti-CCR3 (61828, 5µg/mL, R & D), anti-GalactosylCeramide (mGalC, 10µg/mL, Millipore), anti-Heparan Sulfate-ProteoGlycans (10E4, 5µg/mL, Seikagaku corporation) and anti-p24 gag RD1 (KC57, Beckman coulter).

    Techniques: Expressing, Flow Cytometry, Staining, Real-time Polymerase Chain Reaction, Cell Culture

    HIV-1 alternative receptors expression by primary TGCs and HIV-1 binding inhibition ( A ) Representative profiles of membrane expression of HIV receptors on the whole population of TGC (red) and the n (green), 2n (pink) and 4n DNA (blue) TGC populations. Immunolabeling was performed using specific antibodies against CD4, CCR5, CXCR4, CCR3, GalCer or HSPGs, or, in the case of CD206, after detection of biotinylated-BSA-Mannose (BMA) ligand in the presence (dot-lined histogram) or absence (filled histogram) of mannan competitor. BSA was used as control (open histogram). Cells were further stained with DRAQ-5 for ploidy profile. Specific antibody detection was ensured using isotypes as controls, except for HSPGs where pronase treatment was used. Left panel shows positive controls for each receptor. ( B ) The table shows for each receptor the percentage of positive patients, the median and range of positive cells percentage. ( C ) HIV binding was measured after incubation of TGCs with HIV R5 SF162 (25ng p24) in the presence or absence of CD206 BSA-mannose competitor (BMA), Galactosylceramide specific Mab, HSPGs competitor (heparin) at the 3 indicated doses. Results represent the mean +/- SEM of 3 to 6 independent experiments performed in duplicate and are expressed relative to their respective controls (virus-cell incubation without receptor inhibitors, or in presence of BSA for BSA-mannose). Statistical analysis with non parametric test : Wilcoxon *: p

    Journal: bioRxiv

    Article Title: Potential for virus endogenization in humans through testicular germ cell infection: the case of HIV

    doi: 10.1101/2020.06.04.135657

    Figure Lengend Snippet: HIV-1 alternative receptors expression by primary TGCs and HIV-1 binding inhibition ( A ) Representative profiles of membrane expression of HIV receptors on the whole population of TGC (red) and the n (green), 2n (pink) and 4n DNA (blue) TGC populations. Immunolabeling was performed using specific antibodies against CD4, CCR5, CXCR4, CCR3, GalCer or HSPGs, or, in the case of CD206, after detection of biotinylated-BSA-Mannose (BMA) ligand in the presence (dot-lined histogram) or absence (filled histogram) of mannan competitor. BSA was used as control (open histogram). Cells were further stained with DRAQ-5 for ploidy profile. Specific antibody detection was ensured using isotypes as controls, except for HSPGs where pronase treatment was used. Left panel shows positive controls for each receptor. ( B ) The table shows for each receptor the percentage of positive patients, the median and range of positive cells percentage. ( C ) HIV binding was measured after incubation of TGCs with HIV R5 SF162 (25ng p24) in the presence or absence of CD206 BSA-mannose competitor (BMA), Galactosylceramide specific Mab, HSPGs competitor (heparin) at the 3 indicated doses. Results represent the mean +/- SEM of 3 to 6 independent experiments performed in duplicate and are expressed relative to their respective controls (virus-cell incubation without receptor inhibitors, or in presence of BSA for BSA-mannose). Statistical analysis with non parametric test : Wilcoxon *: p

    Article Snippet: The following antibodies were used: anti-CD45 (-PE or PC7 conjugated, HI30, BD Pharmingen), anti-HLA-ABC-PE (G46-2.6, BD Pharmingen) anti-Vimentin (EPR3776, 1µg/mL, Epitomics), anti-DDX4 (Rabbit polyclonal, 5µg/mL, Abcam), anti-MAGEA4 (clone 57B, 4µg/mL) [ ], anti-CD4 (ARP337, 10µg/mL), anti-CXCR4 (ARP3101 12G5, 10µg/mL) (both from EVA/MRC, NIBSC), anti-CCR5 (45549, 10µg/mL, R & D), anti-CCR3 (61828, 5µg/mL, R & D), anti-GalactosylCeramide (mGalC, 10µg/mL, Millipore), anti-Heparan Sulfate-ProteoGlycans (10E4, 5µg/mL, Seikagaku corporation) and anti-p24 gag RD1 (KC57, Beckman coulter).

    Techniques: Expressing, Binding Assay, Inhibition, Immunolabeling, Staining, Incubation